Snibe shines at MEDLAB Asia Pacific 2018 in Singapore

Release Date:2018-04-02

Snibe attended MEDLAB Asia Pacific 2018 in Singapore from 2nd to 4th in April. With a 72sqm well-decorated exhibition stand at Booth No.K10, Snibe has successfully showcased its excellent MAGLUMI Chemiluminescence Immunoassay (CLIA) system and Integrated System.

MAGLUMI 2000, one of the most brilliant stars of fully-automatic chemiluminescence immunoassay system with FDA cleared, making Snibe became the first and only company focused on CLIA field of China got FDA cleared.

Biolumi 8000, the integrated system which can be combined flexibly the immunoassay module, biochemistry module, electrolyte module and sample processing module, has been installed in Asia and Europe already, and will enter the America market soon in the future.

 

Snibe has always kept creating value for human health through continuous innovation. Snibe has exported its products to more than 132 countries with 8000 units installed and got a highly praise of the customers from all over the world so far.

 

Welcome to visit Snibe, the next MEDLAB in 2019.